Additionally, impaired triglyceride metabolism stimulates the secretion of pro-inflammatory cytokines, such as TNF-α, IL-6, and IL-1β, leading to systemic inflammation and endothelial dysfunction—both of which accelerate the progression of atherosclerosis [29]. This evidence concerns the gene IL1B and atherosclerosis.